Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-17 5:15 pm Purchase | 2026-11-09 | 13G | ARDELYX INC ARDX | TANG CAPITAL MANAGEMENT LLC | 14,336,247 5.700% | 14,336,247![]() (New Position) | Filing History |
| 2026-11-16 4:59 pm Purchase | 2026-11-06 | 13G | INOVIO PHARMACEUTICALS INC INO | TANG CAPITAL MANAGEMENT LLC | 17,978,200 9.990% | 17,978,200![]() (New Position) | Filing History |
| 2026-11-16 4:15 pm Purchase | 2026-09-30 | 13G | BOUNDLESS BIO, INC. BOLD | TANG CAPITAL MANAGEMENT LLC | 2,840,635 12.500% | 306,790![]() (+12.11%) | Filing History |
| 2026-11-16 4:15 pm Sale | 2026-09-30 | 13G | CAPRICOR THERAPEUTICS INC CAPR | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -4,099,900![]() (Position Closed) | Filing History |
| 2026-11-16 4:15 pm Purchase | 2026-09-30 | 13G | PMV PHARMACEUTICALS INC PMVP | TANG CAPITAL MANAGEMENT LLC | 7,572,727 9.990% | 2,852,370![]() (+60.43%) | Filing History |
| 2026-11-16 4:15 pm Purchase | 2026-09-30 | 13G | PURETECH HEALTH PLC ADS PRTCY | TANG CAPITAL MANAGEMENT LLC | 17,948,402 7.300% | 5,312,620![]() (+42.04%) | Filing History |
| 2026-10-27 5:51 pm Purchase | 2026-10-20 | 13G | EYEPOINT INC EYPT | TANG CAPITAL MANAGEMENT LLC | 8,250,200 9.600% | 8,250,200![]() (New Position) | Filing History |
| 2026-10-14 5:41 pm Purchase | 2026-10-07 | 13G | SKYE BIOSCIENCE INC SKYE | TANG CAPITAL MANAGEMENT LLC | 263,560 6.000% | 263,560![]() (New Position) | Filing History |
| 2026-10-06 6:20 pm Purchase | 2026-10-06 | 13G | ATEA PHARMACEUTICALS INC AVIR | TANG CAPITAL MANAGEMENT LLC | 4,814,700 6.000% | 4,814,700![]() (New Position) | Filing History |
| 2026-08-21 7:08 pm Purchase | 2026-08-19 | 13G | NANO DIMENSION LTD SPONSORED A NNDM | TANG CAPITAL MANAGEMENT LLC | 19,232,538 9.100% | 2,516,726![]() (+15.06%) | Filing History |
| 2026-08-14 4:15 pm Purchase | 2026-06-30 | 13G | CAPRICOR THERAPEUTICS INC CAPR | TANG CAPITAL MANAGEMENT LLC | 4,099,900 7.100% | 700,000![]() (+20.59%) | Filing History |
| 2026-08-14 4:15 pm Sale | 2026-06-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | -4,941,798![]() (Position Closed) | Filing History |
| 2026-07-27 7:06 pm Purchase | 2026-07-23 | 13D | NANO DIMENSION LTD SPONSORED A NNDM | TANG CAPITAL MANAGEMENT LLC | 16,715,812 7.900% | 2,422,999![]() (+16.95%) | Filing History |
| 2026-07-15 7:53 pm Purchase | 2026-07-13 | 13G | FULCRUM THERAPEUTICS INC FULC | TANG CAPITAL MANAGEMENT LLC | 6,913,329 10.400% | 1,461,529![]() (+26.81%) | Filing History |
| 2026-06-30 7:50 pm Purchase | 2026-06-24 | 13D | NANO DIMENSION LTD SPONSORED A NNDM | TANG CAPITAL MANAGEMENT LLC | 14,292,813 6.800% | 14,292,813![]() (New Position) | Filing History |
| 2026-06-29 7:58 pm Purchase | 2026-06-23 | 13G | BOUNDLESS BIO, INC. BOLD | TANG CAPITAL MANAGEMENT LLC | 2,533,845 11.300% | 2,533,845![]() (New Position) | Filing History |
| 2026-06-10 6:13 pm Purchase | 2026-06-03 | 13G | FULCRUM THERAPEUTICS INC FULC | TANG CAPITAL MANAGEMENT LLC | 5,451,800 8.200% | 5,451,800![]() (New Position) | Filing History |
| 2026-06-04 6:44 pm Purchase | 2026-06-02 | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT LLC | 13,044,106 10.000% | 814,606![]() (+6.66%) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | ALTIMMUNE INC ALT | TANG CAPITAL MANAGEMENT LLC | 666,022 0.300% | 666,022![]() (New Position) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | TANG CAPITAL MANAGEMENT LLC | 1,160,000 4.210% | 460,000![]() (+65.71%) | Filing History |

